Seventeen target genes (3.8%) for hsa-miR-222-3p are involved in cancer-related pathways (P = 4.44 × 10−6), 9 (2.0%) in ErbB signaling (P = 1.17 × 10−5), 11 (2.5%) in Wnt signaling (P = 1.26 × 10−5), and 13 (2.9%) in MAPK signaling (P = 9.29 × 10−5; Table 4C). The gene discussed is EGFR; the disease is cancer.